These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets. Chue P, Eerdekens M, Augustyns I, Lachaux B, Molcan P, Eriksson L, Pretorius H, David AS. Eur Neuropsychopharmacol; 2005 Jan; 15(1):111-7. PubMed ID: 15572280 [Abstract] [Full Text] [Related]
3. Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies. Kane JM. J Clin Psychiatry; 2003 Jan; 64 Suppl 16():34-40. PubMed ID: 14680417 [Abstract] [Full Text] [Related]
9. Hospitalisation and resource utilisation in patients with schizophrenia following initiation of risperidone long-acting therapy in the Veterans Affairs Healthcare System. Fuller M, Shermock K, Russo P, Secic M, Dirani R, Vallow S, Flanders S. J Med Econ; 2009 Sep; 12(4):317-24. PubMed ID: 19817665 [Abstract] [Full Text] [Related]
12. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [Abstract] [Full Text] [Related]
16. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection. Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720 [Abstract] [Full Text] [Related]
17. Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmacodynamics. Ereshefsky L, Mascarenas CA. J Clin Psychiatry; 2003 Nov; 64 Suppl 16():18-23. PubMed ID: 14680415 [Abstract] [Full Text] [Related]
18. Clinical experience and management considerations with long-acting risperidone. Parellada E. Curr Med Res Opin; 2006 Feb; 22(2):241-55. PubMed ID: 16466596 [Abstract] [Full Text] [Related]
19. A cross-sectional study of plasma risperidone levels with risperidone long-acting injectable: implications for dopamine D2 receptor occupancy during maintenance treatment in schizophrenia. Ikai S, Remington G, Suzuki T, Takeuchi H, Tsuboi T, Den R, Hirano J, Tsunoda K, Nishimoto M, Watanabe K, Mimura M, Mamo D, Uchida H. J Clin Psychiatry; 2012 Aug; 73(8):1147-52. PubMed ID: 22967779 [Abstract] [Full Text] [Related]
20. A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia. Li H, Rui Q, Ning X, Xu H, Gu N. Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun 01; 35(4):1002-8. PubMed ID: 21315787 [Abstract] [Full Text] [Related] Page: [Next] [New Search]